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abstract: Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing mesenchymal neoplasm of the 
dermis and subcutaneous tissues that has a low- to intermediate-grade malignancy. DFSP commonly involves the 
trunk and extremities, and very rarely the breast skin, mimicking a primary breast neoplasm with few reported 
cases in the literature. We report a 35-year old female patient who was referred to the Royal Hospital, Muscat, 
Oman in 2017, with a two-year history of a slow growing left breast lump. Assessment of the breasts with 
mammography revealed a lobulated lesion in the left-upper-inner quadrant with neither microcalcification nor 
architectural distortion, mimicking a benign lesion. However, on ultrasound, the lesion had suspicious features 
with increased vascularity and hence, it was categorised as breast imaging reporting and data system (BIRAD) IV. 
The patient underwent left breast wide local excision and the histopathological diagnosis was dermatofibrosarcoma 
protuberans.
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امللخ�ص: ال�شاركوما الليفية اجللدية احلدبية هي ورم نادر وبطيء النمو من اورام اللُّْحَمُة املتو�شطة والتي ت�شيب الأدمة والأن�شجة حتت اجللد، 
وتعترب ورمَا خبيثَا منخف�ض اإىل متو�شط الدرجة. عادة ما تظهر ال�شاركوما الليفية اجللدية احلدبية يف اجلذع والأطراف، ويف حالت نادرة 
جدا قد ت�شيب اجللد الذي يغطي الثدي حماكيًة اأورام الثدي الولية مع عدد قليل من احلالت املبلغ عنها يف الأدبيات. نعر�ض هنا حالة لمراأة 
تبلغ من العمر 35 عاًما مت حتويلها اإىل امل�شت�شفى ال�شلطاين يف م�شقط، �شلطنة ُعمان عام 2017، لديها كتلة بطيئة النمو يف الثدي الي�رص ملدة 
�شة يف الربع الإْن�ِشّي العلوي للثدي الي�رص بدون وجود  عامني. وقد ك�شف تقييم الثدي با�شتخدام ت�شوير الثدي ال�شعاعي عن وجود اآفة ُمَف�شَّ
تكل�ض جمهري اأو ت�شوه يف البناء الن�شيجي حماكيَة اآفة حميدة، يف حني اأظهر ا�شتخدام جهاز املوجات فوق ال�شوتية �شمات مريبة للآفة مع 
زيادة يف الوعية الدموية وبالتايل مت ت�شنيف الورم على انه من الفئة 4 ح�شب نظام الإبلغ عن ت�شوير الثدي والبيانات. خ�شعت املري�شة 
ل�شتئ�شال مو�شعي وا�شع للثدي الأي�رص وجاء الت�شخي�ض املر�شي الن�شيجي على �شكل �شاركوما ليفية جلدية حدبية.
الكلمات املفتاحية: ثدي؛ ال�شاركوما ليفية جلدية حدبية؛ ت�شوير باملوجات فوق ال�شوتية؛ �شلطنة ُعمان.
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having imaging findings. In the current case, we report 
the mammographic and ultrasonographic findings of 
a breast skin DFSP in a 35-year-old female patient and 
performed a review of the literature.
Case Report
A 35-year-old female patient was referred from a local 
hospital to the breast surgery outpatient clinic in the 
Royal Hospital, Muscat, Oman, in 2017, with a two-
year history of a slow growing nodular lesion over the 
left breast [Figure 1]. There was no associated nipple 
discharge and no family history of breast cancer.
On physical examination, there was a nodular 
pinkish skin lesion over the upper-inner quadrant 
Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing soft tissue sarcoma that commonly affects young 
to middle aged adults.1 It has intermediate- to low-
grade malignancy with a high propensity for local 
infiltration as well as having a high local recurrence 
rate after excision.2 DFSP most commonly involves 
the trunk, followed by the extremities, and the head 
and neck area.3 However, DFSP very rarely involves 
the breast, mimicking primary breast tumour.1,2,4,5 
Awareness of this rare entity and its typical imaging 
features is crucial to avoid the misdiagnosis of DFSP 
with a benign breast lesion and to suggest a pre-
operative diagnosis. However, reports of imaging 
features have been scarce in the literature compared 
to histopathological features, with few reported cases 
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of the left breast, which was mobile and non-tender, 
measuring 3 × 3 cm. There was a mobile single left 
axillary lymph node. The nipple and areola looked 
normal.
On mammography, there was a lobulated 
mass in the upper-inner quadrant of the left breast 
measuring 3 × 2 cm [Figure 2]. There was neither 
associated microcalcification nor architectural 
distortion. Bilateral axillary lymph nodes were seen 
but demonstrated benign imaging features. Left breast 
ultrasound was performed during the same sitting and 
revealed a subcutaneous lobulated mass measuring 
3 × 1.4 cm. 
On colour Doppler, the lesion showed increased 
vascularity [Figure 3]. Based on the ultrasound 
findings, the lesion was categorised as Breast Imaging-
Reporting and Data System (BIRAD) IV.  Clinical 
examination and imaging findings were suggestive of 
DFSP. Therefore, the patient underwent left breast wide 
local excision with an attempt at a 2 cm gross margin. 
Histologic examination showed a hypercellular spindle 
cell lesion, largely located in the dermis, with irregular 
subcutaneous infiltration; however, there was no 
infiltration of the breast parenchyma. The cells were 
monotonous with occasional mitosis and a storiform 
pattern of arrangement. 
Immunohistochemically, the spindle cells were 
diffusely positive for cluster of differentiation (CD)34 
and negative for pan cytokeratin AE1/AE3 [Figures 
4 and 5]. These findings were consistent with DFSP. 
The patient has been under regular close follow-up for 
three years with breast ultrasonography surveillance 
every six months and has remained disease-free. 
Consent for publication of the present clinical details 
and/or clinical images was obtained from the patient.
Discussion
DFSP is a rare sarcoma of the dermis and subcutaneous 
tissue that has an estimated incidence of 0.8–5 cases 
per one million per year and accounts for less than 6% 
of all sarcomas. It usually affects patients aged between 
20–50 years.6
DFSP has an intermediate- to low-grade 
malignancy with a high predilection for local invasion. 
Although rare, distant metastasis, especially in the 
lungs and lymph nodes, has been reported.7,8 DFSP 
has a high propensity for local recurrence following 
inadequate surgical excision. Moreover, poorly 
treated lesions can lead to differentiation into higher-
grade sarcoma with a higher recurrence rate.9 DFSP 
commonly occurs on the trunk (50–60%), followed by 
the limbs (25%) and the head and neck area (10–15%). 
Involvement of the breast by DFSP is extremely rare, 
with only a few cases reported in the literature.6,9
 
Figure 1: Photograph of the left breast of a 35-year-old 
female patient showing a nodular pinkish skin lesion 
over the upper-inner quadrant measuring 3 × 3 cm.
 
Figure 3: Colour Doppler ultrasound image of the left 
breast of a 35-year-old female patient showing a well-
circumscribed lobulated subcutaneous mass measuring 
3 × 1.4 cm with increased vascularity.
 
Figure 2: A mammogram of a 35-year-old female patient with dermatofibrosarcoma protuberans of left breast. 
Mediolateral oblique (A) and craniocaudal (B) showing a lobulated, smoothly marginated mass in the upper-inner 
quadrant of the left breast. 
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Clinically, DFSP usually appears as an irregular 
reddish-brown to bluish superficial nodule and the 
diagnosis might be suggested from the appearance.6,8,10 
However, DFSP can present as a subcutaneous nodule 
known as subcutaneous DFSP and when it involves 
the breast it can be confused with a primary breast 
lesion.11 The current patient had a superficial nodular 
pinkish nodule.
Histologically, DFSP is composed of 
monomorphous spindle-shaped cells arranged in a 
storiform pattern with scattered mitosis and mild 
nuclear pleomorphism on a background of fibrous 
stroma and infiltration of surrounding subcutaneous 
fat. Immunohistochemically, the tumour is diffusely 
and strongly CD34 positive and negative for 
cytokeratins, smooth muscle actin (SMA), desmin 
and S100.2,12 Dermatofibroma is one of the main 
differential diagnoses for DFSP. Unlike DFSP, tumoural 
cells in dermatofibroma do not show a prominent 
storiform pattern, increased mitotic activity nor 
positive immune histochemical reactivity for CD34. 
Dermatofibroma is a tumour of the dermis, whereas 
DFSP frequently infiltrates the subcutaneous adipose 
tissue.13 Bednar tumour is the pigmented variant 
of DFSP and has similar morphologic properties 
as DFSP. However, Bednar tumour has melanin 
containing dendritic cells.13 Another differential 
diagnosis is malignant fibrous histiocytoma (MFH). 
Marked nuclear pleomorphism, increased mitotic 
activity and necrosis are detected in MFH and tumour 
cells are negative for CD34.14 The current case was 
differentiated from leiomyoma and leiomyosarcoma 
by immunohistochemical positivity for CD34 and 
negativity for SMA, along with its morphological 
characteristics.
On mammography, breast DFSP appears as a skin-
based or intra-mammary located well-circumscribed 
oval-shaped lesion with no microcalcification nor 
speculation. These mammography findings are not 
specific and hence, breast DFSP can mimic a benign 
breast lesion such as fibroadenoma, sebaceous cyst or 
an abscess.1,4,5,9,15 In the current case, the mammography 
findings were consistent with findings reported in the 
literature with a skin-based well-defined lesion with 
no microcalcification nor architectural distortion, 
mimicking a sebaceous cyst.
Ultrasonographically, breast DFSP appears as 
a skin-based or subcutaneous, well-circumscribed 
hypoechoic lesion with mild lobulation and increased 
vascularity on colour Doppler. Increased vascularity 
can be used to differentiate DFSP from benign breast 
lesions that usually appear as well-circumscribed 
lesions such as sebaceous cysts and liver abscesses. 
Another useful ultrasonographic finding that can help 
to distinguish DFSP is the presence of a peripheral 
hyperechoic rim in the subcutaneous tissue that 
represents a mixture of tumour cells and fibrous tissue 
infiltrating the subcutaneous fat.1,2,4,5,9,11 
On magnetic resonance imaging (MRI), DSFP 
has no specific features and appears as a well-defined 
nodule or mass that is T1 isointense to the muscle and 
shows homogenous or heterogenous enhancement on 
post-contrast examination. However, owing to its high 
spatial resolution and high tissue characterisation, 
MRI is very helpful in delineation of tumour extent 
and evaluating the anatomical relation of the tumour 
to adjacent structures.2,3,9 
Due to its infiltrative behaviour, DFSP tends to 
extend beyond the clinical margin. This explains the 
high local recurrence rate of 20–50% following local 
excision and justifies the current recommendation of a 
wide local excision with a 2–3 cm resection margin.2,6,10 
Radiation therapy can be used in inoperable and 
metastatic cases. It is estimated that about 80–90% 
of DFSP tumours have a fusion gene that results in 
continuous activation of the platelet-derived growth 
factor-β (PDGF-β) signalling pathway. Therefore, 
molecular targeted therapy inhibiting PDGF-β is an 
effective option for inoperable and metastatic DFSP. 
Multikinase inhibitor imatinib is the first agent to be 
approved for systemic treatment of DFSP and has 
 
Figure 4: Histopathologic findings of the left breast 
lesion in a 35-year-old female patient. A: Hematoxylin 
and eosin (H&E) stain at x40 magnification. The 
tumour was hypercellular and composed of spindle cells 
arranged in a storiform pattern. B: H&E stain  at x200 
magnification showing that the tumour was infiltrating 
the subcutaneous tissue.
 
Figure 5: Histopathologic findings of the left breast 
lesion in a 35-year-old female patient. A: Hematoxylin 
and eosin stain at x400 magnification demonstrating 
storiform arrangement of short spindle cells and mitotic 
figures. B: The tumor cells show positive immune 
histochemical reactivity for CD34.
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shown objective response rates of approximately 50% 
in clinical trials.16 Imatinib treatment has been also 
used for metastatic DFSP.17 Long-term follow-up 
requires strict monitoring every 6–12 months with 
ultrasound and tissue biopsy in cases of suspected 
recurrence. The 10-year survival rate is >99%.18
Conclusion
Breast skin DFSP is a rare entity that can mimic a 
primary breast tumour. Awareness of this rare lesion 
and its typical imaging features will help to avoid the 
misdiagnosis of DFSP with a benign breast lesion and 
suggest a pre-operative diagnosis.
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